- 560
- 329 272
EASL - Home of Hepatology
Switzerland
Приєднався 17 жов 2011
EASL, the leading liver association in Europe
In the 48 years since EASL was founded, it has grown from a small organisation that played host to 70 participants at its first meeting, to becoming the leading liver association in Europe.
EASL attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education, and promoting changes in european liver policy.
In the 48 years since EASL was founded, it has grown from a small organisation that played host to 70 participants at its first meeting, to becoming the leading liver association in Europe.
EASL attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education, and promoting changes in european liver policy.
EASL Studio S7 E4 Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?
This episode will explore the latest developments in liver disease, with a focus on metabolic-associated steatotic liver disease (MASLD) and its impact on liver cancer, particularly hepatocellular carcinoma (HCC). The main focus will be the emerging role of advanced imaging technologies. The discussion will:
Compare traditional ultrasound with advanced imaging techniques.
Examine AI-based approaches in patient classification.
The episode will conclude with a forward-looking perspective on the future management of MASLD.
This EASL Studio is supported by Bayer. EASL has received no input from Bayer with regards to the content of this programme.
Compare traditional ultrasound with advanced imaging techniques.
Examine AI-based approaches in patient classification.
The episode will conclude with a forward-looking perspective on the future management of MASLD.
This EASL Studio is supported by Bayer. EASL has received no input from Bayer with regards to the content of this programme.
Переглядів: 149
Відео
EASL Policy Dialogues S3 E8 - Current initiatives and developments in alcohol policies in Europe
Переглядів 5421 день тому
In this episode our speakers Sheila Gilheany and Catherine Paradis explore the health impact of alcohol consumption in Ireland and the key lessons from its Alcohol Harm Reduction policies. We also discuss the European Alcohol Health Alliance’s mission to reduce alcohol-related harm, its connection to the WHO Alcohol Policy Playbook, and what the future holds for this vital partnership. Tune in ...
EASL Studio S7E10 - The liver as a master regulator of ageing, health, and longevity
Переглядів 152Місяць тому
This EASL Studio showcases cutting-edge research elucidating the role of the liver in ageing and exploring its role as a regulator of health and longevity. In particular, the liver’s function in modulating systemic ageing, its ability to buffer genetic and metabolic disturbances, and its influence on the progression of age-related diseases is discussed. Last but not least, panelists provides ne...
EASL Policy Dialogues S3 E7: Transforming Liver Health in Europe
Переглядів 56Місяць тому
EASL Policy Dialogues S3 E7: Transforming Liver Health in Europe: Policy, Prevention, and Cancer Screening Initiatives Join us for an insightful discussion on "Innovation in Liver Cancer Screening and Prevention," featuring Directorate-General Sandra Gallina and Prof. Professor Shira Zeiber-Sagi. In this engaging video, our speakers delve into Europe’s Beating Cancer Plan, highlighting its ambi...
EASL Studio S7E09 - TIPS: How far can we go?
Переглядів 318Місяць тому
This EASL Studio episode examines the current relevance of Hepatic Encephalopathy (HE) and the roles of hepatologists and interventional radiologists in patient care. The discussion covers technical approaches, patient outcomes, and the expanding indications for TIPS. You can also watch this episdoe on deman on EASL Campus: easlcampus.eu/videos/easl-studio-s7-e9 Or listen to the Podcast on your...
EASL Studio S7E10 - The Liver as a master regulator of ageing, health, and longevity
Переглядів 357Місяць тому
This EASL Studio highlights groundbreaking research on the liver's role in ageing, health, and longevity. Discussions will explore how the liver modulates systemic ageing, buffers genetic and metabolic disturbances, and influences age-related diseases. Experts will also share insights into liver-targeted therapies for promoting healthy ageing. Available on demand on #EASLCampus 📺easlcampus.eu/v...
EASL Studio S7E9 - Promo video - TIPS: How far can we go?
Переглядів 6672 місяці тому
This EASL Studio episode examines the current relevance of Hepatic Encephalopathy (HE) and the roles of hepatologists and interventional radiologists in patient care. The discussion covers technical approaches, patient outcomes, and the expanding indications for TIPS. Tune in on Wednesday 4 December at 18:00 to: Learn about the critical roles of hepatologists and radiologists in managing HE. Un...
EASL Studio S7E8 - Sarcopenia: Converting research findings into clinical practice
Переглядів 2552 місяці тому
Sarcopenia: Converting research findings into clinical practice - Are we doing enough? Sarcopenia, defined by a reduction in muscle mass and strength, significantly increases the risk of hospitalisation and mortality in patients with liver cirrhosis. This EASL Studio episode highlights the importance of incorporating sarcopenia assessment and management into routine clinical practice. Experts d...
EASL Studio S7E08 - Promo video
Переглядів 4482 місяці тому
Sarcopenia: Converting research findings into clinical practice - Are we doing enough? Sarcopenia, defined by a reduction in muscle mass and strength, significantly increases the risk of hospitalisation and mortality in patients with liver cirrhosis. This EASL Studio episode highlights the importance of incorporating sarcopenia assessment and management into routine clinical practice. Experts d...
EASL Studio S7E7- Alcohol, cardiometabolic risks factors & SLD - Stigma to breakthrough therapies
Переглядів 1782 місяці тому
This EASL Studio episode explores how alcohol worsens liver disease in patients with cardiometabolic risks, the stigma affecting diagnosis and care, and the latest therapeutic advances. Key topics of discussion include: Interaction between alcohol and cardiometabolic risks Stigma and its impact on patient care Identifying at-risk patients with clinical markers Emerging therapies and research op...
EASL Studio S7E6 - What’s hot and not in liver transplantation: EASL CPG 2024 update
Переглядів 2252 місяці тому
Join the experts as they explore the new updates to the liver transplantation clinical practice guidelines, and delve into the latest advancement and ongoing challenges faced in this field. Tune in to: Discover cutting-edge techniques like machine perfusion and extended criteria grafts. Learn about new transplant indications, including oncology and acute liver failure. Understand challenges in ...
S7E06 Promo - What's hot and not in liver transplantation: EASL CPG 2024 update
Переглядів 5442 місяці тому
Join the experts as they explore the new updates to the liver transplantation clinical practice guidelines, and delve into the latest advancement and ongoing challenges faced in this field. Tune in to: - Discover cutting-edge techniques like machine perfusion and extended criteria grafts. - Learn about new transplant indications, including oncology and acute liver failure. - Understand challeng...
EASL Studio - S7E7 - Alcohol, cardiometabolic risks factors & SLD
Переглядів 4802 місяці тому
This EASL Studio episode explores how alcohol worsens liver disease in patients with cardiometabolic risks, the stigma affecting diagnosis and care, and the latest therapeutic advances. Key topics of discussion will include: - Interaction between alcohol and cardiometabolic risks - Stigma and its impact on patient care - Identifying at-risk patients with clinical markers - Emerging therapies an...
Love Your Liver - EASL Congress 2024 - Milan
Переглядів 1373 місяці тому
Love Your Liver - EASL Congress 2024 - Milan
EASL Policy Dialogues - Liver disease representation at the 4th high level meeting on NCDs in 2025
Переглядів 1823 місяці тому
A seat at the table: liver disease representation at the fourth high level meeting on NCDs in 2025 In this episode, speakers will discuss the critical need for liver disease representation at the upcoming high-level meeting on non-communicable diseases (NCDs) in 2025. Topics will explore how the WHO’s newly adopted "best buys" target risk factors for liver disease and why prioritizing liver hea...
EASL Studio S7E5 - Why does WHO engagement with Steatotic Liver Disease matter?
Переглядів 2743 місяці тому
EASL Studio S7E5 - Why does WHO engagement with Steatotic Liver Disease matter?
EASL Studio S7E5 Promo - Why does WHO engagement with Steatotic Liver Disease matter?
Переглядів 2214 місяці тому
EASL Studio S7E5 Promo - Why does WHO engagement with Steatotic Liver Disease matter?
EASL Studio S7E4 Promo - Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?
Переглядів 5104 місяці тому
EASL Studio S7E4 Promo - Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?
EASL Policy Dialogues - Enhancing Treatment Adherence & Quality of life in Rare Liver Disease
Переглядів 1224 місяці тому
EASL Policy Dialogues - Enhancing Treatment Adherence & Quality of life in Rare Liver Disease
EASL Studio S7E03 - The Changing Face of Steatotic Liver Disease
Переглядів 3654 місяці тому
EASL Studio S7E03 - The Changing Face of Steatotic Liver Disease
EASL Studio S7E01 Promo - Are we relearning how to manage renal dysfunction in cirrhosis?
Переглядів 6375 місяців тому
EASL Studio S7E01 Promo - Are we relearning how to manage renal dysfunction in cirrhosis?
EASL Policy Dialogues - Inspiring Innovative Action Towards Viral Hepatitis Elimination
Переглядів 1025 місяців тому
EASL Policy Dialogues - Inspiring Innovative Action Towards Viral Hepatitis Elimination
EASL Policy Dialogues - EASL’s statement: Key asks to the EU for the Liver
Переглядів 1247 місяців тому
EASL Policy Dialogues - EASL’s statement: Key asks to the EU for the Liver
EASL Congress 2024 - Wrap up on Metabolism, Alcohol & Toxicity
Переглядів 1,9 тис.7 місяців тому
EASL Congress 2024 - Wrap up on Metabolism, Alcohol & Toxicity
EASL Congress 2024 - Wrap up on Liver Tumours
Переглядів 1,3 тис.7 місяців тому
EASL Congress 2024 - Wrap up on Liver Tumours
EASL Congress 2024 - Wrap up on Viral Hepatitis
Переглядів 2,2 тис.7 місяців тому
EASL Congress 2024 - Wrap up on Viral Hepatitis
EASL Congress 2024 - Wrap up on Immune-mediated & Cholestatic Diseases
Переглядів 1,2 тис.7 місяців тому
EASL Congress 2024 - Wrap up on Immune-mediated & Cholestatic Diseases
EASL Congress 2024 - Wrap up on Cirrhosis & Complications
Переглядів 2 тис.7 місяців тому
EASL Congress 2024 - Wrap up on Cirrhosis & Complications
EASL Congress 2024 - Wrap up on Basic Science
Переглядів 6557 місяців тому
EASL Congress 2024 - Wrap up on Basic Science
EASL Love Your Liver projects in Milan, Italy!
Переглядів 3267 місяців тому
EASL Love Your Liver projects in Milan, Italy!